TH173727A - Pharmaceutical composition for the treatment of gastrointestinal diseases - Google Patents

Pharmaceutical composition for the treatment of gastrointestinal diseases

Info

Publication number
TH173727A
TH173727A TH1701003764A TH1701003764A TH173727A TH 173727 A TH173727 A TH 173727A TH 1701003764 A TH1701003764 A TH 1701003764A TH 1701003764 A TH1701003764 A TH 1701003764A TH 173727 A TH173727 A TH 173727A
Authority
TH
Thailand
Prior art keywords
pharmaceutical composition
treatment
gastrointestinal diseases
formula
particle size
Prior art date
Application number
TH1701003764A
Other languages
Thai (th)
Other versions
TH173727B (en
Inventor
โช
โฮ ยัง
ลี
อู จุน
Original Assignee
ดร.พูนเดช ไกรฤทธิ์
Filing date
Publication date
Application filed by ดร.พูนเดช ไกรฤทธิ์ filed Critical ดร.พูนเดช ไกรฤทธิ์
Publication of TH173727B publication Critical patent/TH173727B/en
Publication of TH173727A publication Critical patent/TH173727A/en

Links

Abstract

สิทธิบัตรยา Drug patent

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แก้ไขใหม่ 17/7/2560: Privilege (item one) which will appear on the advertisement page: new amendment 17/7/2017 1. องค์ประกอบเภสัชภัณฑ์สำหรับรักษาโรคทางเดินอาหารซึ่งประกอบรวมด้วยรานิทิดีน, ซู คราลเฟตและบิสมัธซับซิเตรตเป็นส่วนผสมออกฤทธิ์, และเป็นไปตามอย่างน้อยหนึ่งข้อจากเงื่อนไข ต่อไปนี้: (a) ซูคราลเฟตมีขนาดอนุภาคโดยเฉลี่ยเท่ากับ 1 ถึง 25 (สูตร)m (b) บิสมัธซับซิเตรตมีขนาดอนุภาคโดยเฉลี่ยเท่ากับ 5 ถึง 90 (สูตร)mแท็ก : สิทธิบัตรยา1. Gastrointestinal Pharmaceutical Composition, which contains ranitidine, sucralphate and bismuth substrate as active ingredients, and is subject to at least one of the conditions. Following: (a) sucralphates have an average particle size of 1 to 25 (formula) m (b) Bismuth substrate has an average particle size of 5 to 90 (formula) m. Tag: drug patent
TH1701003764A 2016-01-28 Pharmaceutical composition for the treatment of gastrointestinal diseases TH173727A (en)

Publications (2)

Publication Number Publication Date
TH173727B TH173727B (en) 2018-03-02
TH173727A true TH173727A (en) 2018-03-02

Family

ID=

Similar Documents

Publication Publication Date Title
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
TH173727A (en) Pharmaceutical composition for the treatment of gastrointestinal diseases
EA032385B9 (en) Pharmaceutical composition for treating gastrointestinal diseases
TH173727B (en) Pharmaceutical composition for the treatment of gastrointestinal diseases
TH1901004308A (en) The pharmaceutical composition contains sul glycotide or its salts, which are pharmaceutically acceptable, prevention or treatment of dry eye syndrome.
DE602008004675D1 (en) FORMULATIONS OF ORGANIC PLATINUM COMPOUNDS IN THE PRESENCE OF ASSOCIATIVE POLYMERS, PRODUCTS OBTAINED THEREOF, AND THEIR APPLICATIONS
TH152475A (en) Fluoromethyl-5,6-Dihydro-4H- [1,3] oxacene
TH181349S (en) Powder
TH1901004650A (en) New heterocyclic compounds, their preparation methods and pharmaceutical compositions which combine them.
TH174277A (en) Applications of volatile compounds that resist pathogens
TH168501A (en) Solid composition of triglycerides and their use
TH181357S (en) Powder
TH170532A (en) Anti-infection agent
TH1701000488A (en) Drug delivery devices through the skin
TH1701001291A (en) A spirocyclic inhibitor of cathepsin C.
TH157309S (en) Agricultural products
TH182826A (en) Thyazine compounds and their use for medical purposes
TH1701002129A (en) Composition Which contains extracts from the genus Justicia or their separate extracts
TH157346S (en) Bed
TH1701000457A (en) Bicyclic dihydropyrimidinone displacement And their use as an active inhibitor of neutrophil elastase.
TH157959S (en) Bed
TH152515A (en) 5-amino [1,4] thiazine (5-Amino [1,4] Thiazine) as a BACE 1 inhibitor.
TH174277B (en) Application of volatile compounds that resist pathogens
TH157341S (en) Center table
TH160309S (en) Center table